The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep disorders.
Study Type
OBSERVATIONAL
Enrollment
8,616
This was an observational study. Therefore, the physician decided about dosage according to individual needs.
Assessment of the Severity of Sleep Disturbances
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: first and last visit (after a median of 18 days)
Assessment of Change of Quality of Sleep During Therapy With Pantoprazole
Physician's assessment on a scale with * considerably improved * improved * unchanged
Time frame: last visit (after a median of 18 days)
Assessment of the Severity of Heartburn
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: first and last visit (after a median of 18 days)
Assessment of the Severity of Eructation/Acid Eructation
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: first and last visit (after a median of 18 days)
Assessment of the Severity of Epigastric Complaints/Epigastric Pain
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: first and last visit (after a median of 18 days)
Assessment of the Severity of Sensation of Fullness/Abdominal Distension
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: first and last visit (after a median of 18 days)
Assessment of the Efficacy of Pantoprazole at Final Visit
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Nycomed Deutschland GmbH
Aachen, Germany
Nycomed Deutschland GmbH
Aachen, Germany
Nycomed Deutschland GmbH
Aalen, Germany
Nycomed Deutschland GmbH
Achern, Germany
Nycomed Deutschland GmbH
Achim, Germany
Nycomed Deutschland GmbH
Adenau, Germany
Nycomed Deutschland GmbH
Adorf, Germany
Nycomed Deutschland GmbH
Ahrensburg, Germany
Nycomed Deutschland GmbH
Aicha, Germany
Nycomed Deutschland GmbH
Albstadt, Germany
...and 1143 more locations
Time frame: last visit (after a median of 18 days)
Assessment of the Tolerability of Pantoprazole at Final Visit
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Time frame: last visit (after a median of 18 days)